Nasdaq
PCI Biotech: Mandatory notification regarding trade of shares
29-08-2019
Borkenholm AS has on 29 August 2019 bought 4,000 shares in PCI Biotech Holding ASA ("PCI Biotech") at an average price of NOK 26.90 per share. Borkenholm AS is a related party to board member Hilde Furberg.
After the transaction, Hilde Furberg and her related parties holds 4,000 shares in PCI Biotech.
This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.
Latest Health & Supplement Reviews
- YuSleep Reviews (EXPOSED) Doctor Explains Deep Sleep Benefits, Hidden Risks & Real Consumers Results In 2026
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability